Literature DB >> 26494674

High-Quality Draft Genome Sequence of Aneurinibacillus migulanus ATCC 9999T (DSM 2895), a Gramicidin S-Producing Bacterium Isolated from Garden Soil.

Jie-Ping Wang1, Bo Liu2, Guo-Hong Liu1, Ci-Bin Ge1, Rong-Feng Xiao1, Xue-Fang Zheng1, Huai Shi1.   

Abstract

Aneurinibacillus migulanus ATCC 9999(T) (DSM 2895) is a Gram-positive, round-spore-forming, and gramicidin S-producing bacterium. Here, we report the 6.35-Mb high-quality draft genome sequence of A. migulanus ATCC 9999(T), which will provide useful information for the genomic taxonomy and phylogenomics of Bacillus-like bacteria.
Copyright © 2015 Wang et al.

Entities:  

Year:  2015        PMID: 26494674      PMCID: PMC4616181          DOI: 10.1128/genomeA.01227-15

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

The Bacillus-like strain ATCC 9999T (DSM 2895) was isolated by R. Synge from Moscow, Russia, and initially identified as a member of Bacillus brevis (now Brevibacillus brevi) (1). In 1993, the strain ATCC 9999T was identified as a unique species and named as Bacillus migulanus sp. nov. (1). In 1996, however, Bacillus migulanus was reclassified as Aneurinibacillus migulanus comb. nov. belonging to the family Paenibacillaceae but not the family Bacillaceae (2). It is of great applicable significance that A. migulanus is a promising biocontrol agent against a range of plant-pathogenic bacteria and fungi, due to its ability to produce the antimicrobial peptide gramicidin S (3–5). Given the physiological properties and application prospects of A. migulanus, its type strain ATCC 9999T was selected as one of the research objects in our “genome sequencing project for genomic taxonomy and phylogenomics of Bacillus-like bacteria.” Although two genome sequences of A. migulanus were reported (JYBN01000000 with 82 scaffolds and JYBO01000000 with 89 scaffolds) (4, 5), here, we presented the third draft genome sequence with higher quality (just 28 scaffolds). The genome sequencing of A. migulanus ATCC 9999T (DSM 2895) was performed via the Illumina Hieseq 2500 system. Two DNA libraries with insert sizes of 500 and 5,000 bp were constructed and sequenced. After filtering of the 1.14-Gb raw data, the 1.10-Gb clean data was obtained, providing approximately 200-fold coverage. The reads were assembled via the SOAPdenovo software version 1.05 (6), using a key parameter K setting at 71. Through the data assembly, 28 scaffolds with total length 6,348,994 bp were obtained, and the scaffold N50 was 4,944,581 bp. The average length of the scaffolds was 226,749 bp, and the longest and shortest scaffolds were 4,944,581 bp and 506 bp, respectively. A total of 91.49% clean reads could be aligned back to the genome, which covered 99.75% of the sequence. The annotation of the genome was performed using the NCBI Prokaryotic Genomes Automatic Annotation Pipeline (PGAAP) (http://www.ncbi.nlm.nih.gov/genome/annotation_prok/) utilizing GeneMark, Glimmer, and tRNAscan-SE tools (7). A total of 6,273 genes were predicted, including 5,673 coding sequences (CDS), 504 pseudo genes, 85 tRNAs, and 12 rRNA genes. There were 3,938 and 2,984 genes assigned to COG and KEGG databases, respectively. The average DNA G+C content was 43.06%, agreeing with the values 43.04% of JYBN01000000 and 43.16% of JYBO01000000 (4, 5) but disagreeing slightly with the value 42.5 mol% acquired by HPLC determination (1).

Nucleotide sequence accession numbers.

This whole-genome shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession no. LGUG00000000. The version described in this paper is version LGUG01000000.
  7 in total

1.  The ability of Aneurinibacillus migulanus (Bacillus brevis) to produce the antibiotic gramicidin S is correlated with phenotype variation.

Authors:  Marina Berditsch; Sergii Afonin; Anne S Ulrich
Journal:  Appl Environ Microbiol       Date:  2007-08-24       Impact factor: 4.792

2.  De novo assembly of human genomes with massively parallel short read sequencing.

Authors:  Ruiqiang Li; Hongmei Zhu; Jue Ruan; Wubin Qian; Xiaodong Fang; Zhongbin Shi; Yingrui Li; Shengting Li; Gao Shan; Karsten Kristiansen; Songgang Li; Huanming Yang; Jian Wang; Jun Wang
Journal:  Genome Res       Date:  2009-12-17       Impact factor: 9.043

3.  Proposal for two new genera, Brevibacillus gen. nov. and Aneurinibacillus gen. nov.

Authors:  O Shida; H Takagi; K Kadowaki; K Komagata
Journal:  Int J Syst Bacteriol       Date:  1996-10

4.  Characterization of Bacillus brevis with descriptions of Bacillus migulanus sp. nov., Bacillus choshinensis sp. nov., Bacillus parabrevis sp. nov., and Bacillus galactophilus sp. nov.

Authors:  H Takagi; O Shida; K Kadowaki; K Komagata; S Udaka
Journal:  Int J Syst Bacteriol       Date:  1993-04

5.  Draft Genome Sequence of Aneurinibacillus migulanus NCTC 7096.

Authors:  Faizah N Alenezi; Hedda J Weitz; Lassaad Belbahri; Jedidi Nidhal; Lenka Luptakova; Marcel Jaspars; Stephen Woodward
Journal:  Genome Announc       Date:  2015-04-02

6.  Draft Genome Sequence of Aneurinibacillus migulanus Strain Nagano.

Authors:  Faizah N Alenezi; Hedda J Weitz; Lassaad Belbahri; Hassen Ben Rebah; Lenka Luptakova; Marcel Jaspars; Stephen Woodward
Journal:  Genome Announc       Date:  2015-04-02

7.  The RAST Server: rapid annotations using subsystems technology.

Authors:  Ramy K Aziz; Daniela Bartels; Aaron A Best; Matthew DeJongh; Terrence Disz; Robert A Edwards; Kevin Formsma; Svetlana Gerdes; Elizabeth M Glass; Michael Kubal; Folker Meyer; Gary J Olsen; Robert Olson; Andrei L Osterman; Ross A Overbeek; Leslie K McNeil; Daniel Paarmann; Tobias Paczian; Bruce Parrello; Gordon D Pusch; Claudia Reich; Rick Stevens; Olga Vassieva; Veronika Vonstein; Andreas Wilke; Olga Zagnitko
Journal:  BMC Genomics       Date:  2008-02-08       Impact factor: 3.969

  7 in total
  1 in total

1.  Genome-Driven Discovery of Enzymes with Industrial Implications from the Genus Aneurinibacillus.

Authors:  Majid Rasool Kamli; Nada A Y Alzahrani; Nahid H Hajrah; Jamal S M Sabir; Adeel Malik
Journal:  Microorganisms       Date:  2021-02-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.